Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dendritic cell–T cell immunological synapse is a highly organized, dynamic interface formed between a professional antigen-presenting cell (APC) and a T lymphocyte (Dustin, 2014). This structure is essential for the precise delivery of signals required for T cell activation, including the primary signal from the T cell receptor (TCR) binding to the peptide-MHC complex and secondary co-stimulatory or co-inhibitory signals (Grakoui et al., 1999). The synapse is spatially organized into supramolecular activation clusters (SMACs), which facilitate efficient signal transduction and cytokine secretion while maintaining specificity (Mellman & Steinman, 2001). In oncology, many therapies target molecules within this synapse, such as PD-1 or CTLA-4, to overcome tumor-induced immune suppression (Pardoll, 2012). Conversely, in autoimmune and inflammatory diseases, drugs like Abatacept modulate this interface to inhibit pathological T cell responses (Bluestone et al., 2006). Because it is a complex cellular interaction rather than a single protein, it represents a functional site for multi-target therapeutic intervention rather than a single molecular target.
Modulation of co-stimulatory and co-inhibitory signaling pathways within the organized interface between dendritic cells and T cells to regulate immune activation or tolerance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell–T cell immunological synapse (DC-T IS).